Analystreport

KalVista Pharmaceuticals (NASDAQ:KALV) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com